Placeholder text

The Sanford Guide to Antimicrobial Therapy 2022

The Sanford Guide to Antimicrobial Therapy 2022 Medicine

The Sanford Guide to Antimicrobial Therapy 2022

0 - Default Title
Description
The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following New Drugs - Addition of new drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dosing Adjustment (Table 10F) and QTc Prolongation (Table 10G). Table 1: Initial Choice of Antimicrobial Therapy - Numerous changes including 2021 CDC STI updates, recommendations for resistant infections. Table 5: Recommendations for MDR Bacteria -
Product details
Binding:
Paperback
Release Date:
2022-07-01
Publication Date:
2022-07-01
Publisher:
Antimicrobial Therapy
Languages:
Published: English, Original: English
ISBN10:
1944272194
Currently sold out